Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes.

Gatti G, Soso P, Dell'Angela L, Maschietto L, Dreas L, Benussi B, Luzzati R, Sinagra G, Pappalardo A.

Eur J Cardiothorac Surg. 2015 Jul;48(1):115-20. doi: 10.1093/ejcts/ezu360. Epub 2014 Sep 19.

PMID:
25239446
2.

Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR).

Rousan TA, Pappy RM, Chen AY, Roe MT, Saucedo JF.

Am J Cardiol. 2014 Oct 15;114(8):1136-44. doi: 10.1016/j.amjcard.2014.07.031. Epub 2014 Jul 30.

PMID:
25150136
3.

Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.

McMullan CJ, Lambers Heerspink HJ, Parving HH, Dwyer JP, Forman JP, de Zeeuw D.

Am J Kidney Dis. 2014 Nov;64(5):714-22. doi: 10.1053/j.ajkd.2014.06.008. Epub 2014 Jul 24.

PMID:
25064674
4.

Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.

Park KW, Lee JM, Kang SH, Ahn HS, Kang HJ, Koo BK, Rhew JY, Hwang SH, Lee SY, Kang TS, Kwak CH, Hong BK, Yu CW, Seong IW, Ahn T, Lee HC, Lim SW, Kim HS.

JACC Cardiovasc Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201.

5.

Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study.

Long GH, Cooper AJ, Wareham NJ, Griffin SJ, Simmons RK.

Diabetes Care. 2014 Jun;37(6):1712-20. doi: 10.2337/dc13-1731. Epub 2014 Mar 21.

6.

Significance of an abnormal ankle-brachial index in patients with established coronary artery disease with and without associated diabetes mellitus.

Banerjee S, Vinas A, Mohammad A, Hadidi O, Thomas R, Sarode K, Banerjee A, Garg P, Weideman RA, Little BB, Brilakis ES.

Am J Cardiol. 2014 Apr 15;113(8):1280-4. doi: 10.1016/j.amjcard.2014.01.403. Epub 2014 Jan 31.

PMID:
24602299
7.

Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia.

Spinetti G, Specchia C, Fortunato O, Sangalli E, Clerici G, Caminiti M, Airoldi F, Losa S, Emanueli C, Faglia E, Madeddu P.

Diabetes Care. 2014 May;37(5):1410-7. doi: 10.2337/dc13-2084. Epub 2014 Feb 26.

PMID:
24574344
8.

Sex differences in cardiovascular outcomes, pharmacological treatments and indicators of care in patients with newly diagnosed diabetes: Analyses on administrative database.

Baviera M, Santalucia P, Cortesi L, Marzona I, Tettamanti M, Avanzini F, Nobili A, Riva E, Caso V, Fortino I, Bortolotti A, Merlino L, Roncaglioni MC.

Eur J Intern Med. 2014 Mar;25(3):270-5. doi: 10.1016/j.ejim.2014.01.022. Epub 2014 Feb 18.

PMID:
24556165
9.

Coronary artery bypass in patients with type 2 diabetes: experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Sako EY, Brooks MM, Hardison RM, Schaff H, Frye RL.

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1268-72. doi: 10.1016/j.jtcvs.2013.11.038. Epub 2014 Jan 2.

PMID:
24507404
10.

New strategy for detection of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes based on cardiac multi-detector computed tomography and treadmill test.

Jeong HC, Kim I, Park KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kim YH, Seon HJ, Moon JD, Ahn Y.

Circ J. 2014;78(3):671-8. Epub 2014 Jan 7.

11.

National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011).

Lopez-de-Andres A, Jimenez-GarcĂ­a R, Hernandez-Barrera V, Perez-Farinos N, de Miguel-Yanes JM, Mendez-Bailon M, Jimenez-Trujillo I, de Miguel AG, Pino CG, Carrasco-Garrido P.

Cardiovasc Diabetol. 2014 Jan 3;13:3. doi: 10.1186/1475-2840-13-3.

12.

Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction.

Bonakdar HR, Aslanpour M, Moladoust H, Sadeghipour P, Mohamadi F, Rad MA, Kheirkhah J.

J Tehran Heart Cent. 2014;9(4):166-73. Epub 2014 Jul 6.

13.

Differential prognostic impacts of diabetes over time course after acute myocardial infarction.

Kim HL, Kang SH, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Kim HS, Chae SC, Cho MC, Kim YJ, Kim JH, Ahn Y, Jeong MH, Choi DJ; Other Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigators.

J Korean Med Sci. 2013 Dec;28(12):1749-55. doi: 10.3346/jkms.2013.28.12.1749. Epub 2013 Nov 26.

14.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2013 Nov 11;11:CD008143. doi: 10.1002/14651858.CD008143.pub3. Review.

PMID:
24214280
15.

Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.

Klempfner R, Goldenberg I, Fisman EZ, Matetzky S, Amit U, Shemesh J, Tenenbaum A.

Am J Cardiol. 2014 Jan 1;113(1):12-6. doi: 10.1016/j.amjcard.2013.08.033. Epub 2013 Oct 2.

PMID:
24157192
16.

Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry.

Hulten E, Bittencourt MS, O'Leary D, Shah R, Ghoshhajra B, Christman MP, Montana P, Steigner M, Truong QA, Nasir K, Rybicki F, Hainer J, Brady TJ, Di Carli MF, Hoffmann U, Abbara S, Blankstein R.

Diabetes Care. 2014 Feb;37(2):555-64. doi: 10.2337/dc13-1431. Epub 2013 Oct 15.

PMID:
24130364
17.

Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Shah B, Srinivas VS, Lu J, Brooks MM, Bates ER, Nedeljkovic ZS, Escobedo J, Das GS, Lopez JJ, Feit F.

Am Heart J. 2013 Sep;166(3):519-26. doi: 10.1016/j.ahj.2013.05.017. Epub 2013 Aug 6.

18.

Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients.

Jeong HS, Cho JY, Kim EJ, Yu CW, Ahn CM, Park JH, Hong SJ, Lim DS.

Coron Artery Dis. 2013 Dec;24(8):676-83. doi: 10.1097/MCA.0b013e3283650210.

PMID:
23994881
19.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

20.

Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease.

Kawata T, Daimon M, Hasegawa R, Toyoda T, Sekine T, Himi T, Uchida D, Miyazaki S, Hirose K, Ichikawa R, Maruyama M, Suzuki H, Daida H.

Cardiovasc Diabetol. 2013 Aug 27;12:121. doi: 10.1186/1475-2840-12-121.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk